oxyquinoline has been researched along with Cerebral Pseudosclerosis in 2 studies
Oxyquinoline: An antiseptic with mild fungistatic, bacteriostatic, anthelmintic, and amebicidal action. It is also used as a reagent and metal chelator, as a carrier for radio-indium for diagnostic purposes, and its halogenated derivatives are used in addition as topical anti-infective agents and oral antiamebics.
quinolin-8-ol : A monohydroxyquinoline that is quinoline substituted by a hydroxy group at position 8. Its fungicidal properties are used for the control of grey mould on vines and tomatoes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Wilson's disease is a genetic disorder that causes excessive accumulation of copper in the body, leading to toxic damage, especially in the liver and nervous system." | 1.48 | Biopolymer strategy for the treatment of Wilson's disease. ( Brus, J; Eigner-Henke, S; Hruby, M; Kucka, J; Kukackova, O; Mackova, H; Mattova, J; Pouckova, P; Sedlacek, O; Sefc, L; Stepanek, P; Vetrik, M, 2018) |
| "Wilson's disease is a genetic disorder caused by a malfunction of ATPase 7B that leads to high accumulation of copper in the organism and consequent toxic effects." | 1.40 | Chelating polymeric beads as potential therapeutics for Wilson's disease. ( Hrubý, M; Kučka, J; Mattová, J; Nový, Z; Petřík, M; Poučková, P; Skodová, M; Stěpánek, P; Urbánek, P; Vetrík, M, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vetrik, M | 2 |
| Mattova, J | 2 |
| Mackova, H | 1 |
| Kucka, J | 2 |
| Pouckova, P | 2 |
| Kukackova, O | 1 |
| Brus, J | 1 |
| Eigner-Henke, S | 1 |
| Sedlacek, O | 1 |
| Sefc, L | 1 |
| Stepanek, P | 2 |
| Hruby, M | 2 |
| Skodová, M | 1 |
| Urbánek, P | 1 |
| Petřík, M | 1 |
| Nový, Z | 1 |
2 other studies available for oxyquinoline and Cerebral Pseudosclerosis
| Article | Year |
|---|---|
Biopolymer strategy for the treatment of Wilson's disease.
Topics: Animals; Cellulose; Chitosan; Copper; Copper Radioisotopes; Gastrointestinal Tract; Hepatolenticular | 2018 |
Chelating polymeric beads as potential therapeutics for Wilson's disease.
Topics: Administration, Oral; Animals; Brain; Chelating Agents; Copper; Female; Gastrointestinal Tract; Hepa | 2014 |